Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel adjunctive therapy in Lennox-Gastaut syndrome (Phase 3, double-blind, randomized, placebo-controlled, with open-label extension)
jRCT2080223481Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Lennox-Gastaut syndrome (LGS) comparing Perampanel with Placebo (2 arms). Started Mar 2017; status: completed.
02
Drugs
perampanel
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on jRCT2080223481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223481.